- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Hefei, Anhui, China
- Novo Nordisk Investigational Site Hefei, Anhui, China
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
- Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01991795
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Research Site Alexander City, Alabama, United States
- Research Site Birmingham, Alabama, United States
- Research Site Fairhope, Alabama, United States
- Research Site Huntsville, Alabama, United States
NCT02561338
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing, Jiangsu, China
NCT01400971
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Disease Attributes, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wellington, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Canton, Georgia, United States
NCT02925559
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Centro de Diabetes Curitiba Curitiba, Paraná, Brazil
NCT03021187
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Anniston, Alabama, United States
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Fountain Hills, Arizona, United States
- Novo Nordisk Investigational Site Glendale, Arizona, United States
Completed
Development and Implementation of Ramadan Fasting Algorithm for Singaporeans With Type 2 Diabetes
NCT03314246
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Tan Tock Seng Hospital Singapore
- National Healthcare Group Polyclinic (Bukit Batok) Singapore
NCT02738086
- Conditions
- Amputation, Arterial Occlusive Diseases, Arteriosclerosis, +14 more
- Locations
-
- Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora, Colorado, United States
NCT03783598
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Gamze Ekici Çağlar Ankara, Turkey (Türkiye)
- Zeynep Bahadır Ağce Istanbul, Turkey (Türkiye)
NCT02827708
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
- Novo Nordisk Investigational Site Bermuda Dunes, California, United States
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Costa Mesa, California, United States